Data is not available at this time.
Nova Leap Health Corp. operates as a specialized provider of home-based healthcare services across key markets in the United States and Canada. The company generates revenue primarily through the delivery of essential non-medical and home health care services directly to clients in their residences. Its comprehensive service portfolio includes specialized dementia care, personal care assistance such as bathing and dressing, companionship, meal preparation, medication reminders, and light housekeeping duties. Nova Leap competes within the fragmented but growing home care industry, positioning itself as a trusted provider for seniors and individuals requiring assistance with daily living activities. The company's strategic focus on dementia care represents a specialized niche addressing a critical need within the aging population demographic. By operating in both the U.S. and Canadian markets, Nova Leap leverages cross-border operational experience while navigating different regulatory environments and reimbursement systems. Its asset-light service model emphasizes human capital as the primary driver of value creation and client satisfaction.
For the fiscal year ending December 31, 2024, Nova Leap reported revenue of CAD 25.8 million with net income of CAD 1.38 million, demonstrating profitability in a competitive service sector. The company generated positive operating cash flow of CAD 1.39 million, slightly exceeding its net income, indicating quality earnings. Capital expenditures were minimal at CAD 25,000, reflecting the asset-light nature of its home care business model and efficient capital allocation toward service delivery rather than significant fixed assets.
Nova Leap achieved diluted earnings per share of CAD 0.0157, establishing a baseline of earnings power despite operating in a labor-intensive industry with inherent margin pressures. The minimal capital expenditure requirements relative to operating cash flow generation suggest strong capital efficiency, allowing the company to fund operations internally. The business model demonstrates the ability to convert revenue into cash flow effectively, though scalability remains dependent on managing labor costs and client acquisition efficiency.
The company maintains a conservative financial position with CAD 1.40 million in cash and equivalents against total debt of CAD 2.53 million. This leverage ratio appears manageable given the company's profitable operations and positive cash flow generation. The balance sheet structure supports ongoing operations without significant financial strain, providing flexibility for potential strategic initiatives or weather-ing industry cyclicality while maintaining service quality standards.
Nova Leap currently does not pay dividends, retaining earnings to fund organic growth initiatives and potential strategic acquisitions in the fragmented home care market. The company's growth strategy likely focuses on geographic expansion within existing markets and service line diversification. Demographic trends supporting increased demand for home care services present long-term growth opportunities, though execution depends on effective client acquisition and caregiver recruitment in a competitive labor market.
With a market capitalization of approximately CAD 30.1 million, the company trades at a price-to-earnings multiple derived from its current profitability level. The beta of 1.258 indicates higher volatility than the broader market, reflecting the small-cap nature and sector-specific risks inherent in healthcare services. Market expectations appear to balance growth potential against execution risks in a competitive, regulated industry with demographic tailwinds.
Nova Leap's strategic advantages include its specialized dementia care expertise, established operational footprint in multiple markets, and asset-light business model. The outlook remains cautiously optimistic given favorable demographic trends toward aging populations requiring home-based care. Success will depend on the company's ability to scale operations efficiently while maintaining service quality, navigate regulatory requirements, and effectively compete for both clients and qualified healthcare personnel in tight labor markets.
Company description and financial data provided
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |